OCT Vibrography for Biomechanical Properties of Tissues

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years later Aug 28, 2026 → Aug 28, 2030
See other at-risk trials from Massachusetts General Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 28, 2026 to Aug 28, 2030
    • Eligibility criteria expanded, about 6 words
    • Publications: details revised at 3 of 3 entries
  2. Site contact updatedv9
  3. Site contact updatedv8
  4. Trial status: Not Yet Recruiting to Recruitingv7 Show 5 more changesShow less
    • Primary and study completion dates: Feb 28, 2026 to Aug 28, 2026
    • Enrollment target: 80 to 90
    • Start date changed from estimate of Oct 5, 2023 to Aug 19, 2023
    • Eligibility criteria revised
    • Site details revised
  5. Site contact updatedv6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date: May 5, 2023 to Oct 5, 2023v5
  2. Start date: Mar 20, 2023 to May 5, 2023v4
  3. Re-verified, no change to tracked fieldsv3
  4. Start date: Mar 1, 2023 to Mar 20, 2023
    • Study description expanded, about 2 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall goal of this study is to develop OCT Vibrography (aka OCT elastography) as a novel tool for measuring biomechanical properties of human tissues in vivo.
Trial Details
NCT Number NCT05759780
Lead Sponsor Massachusetts General Hospital
Collaborators: Massachusetts Eye and Ear Infirmary
Conditions
(from sponsor)		 Cornea, Skin Diseases, Gingival Diseases
Related terms Corneal Diseases, Gingival Diseases, Skin Diseases
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov